tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
Advertisement

KalVista Pharmaceuticals (KALV) Similar Stocks

Compare
573 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$16.43
$830.48M
75.91%
8 Buy
0 Hold
0 Sell
Strong Buy
Savara
$6.50
$1.32B
82.58%
6 Buy
0 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$12.79
$821.43M
-50.66%
9 Buy
6 Hold
1 Sell
Moderate Buy
Gossamer Bio
$3.33
$770.75M
344.00%
6 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.53
$983.58M
233.13%
6 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$18.20
$997.03M
-8.16
-13.74%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
16.43
7.09
75.91%
SVRA
Savara
6.50
2.94
82.58%
ARVN
Arvinas Holding Company
12.79
-12.29
-49.00%
GOSS
Gossamer Bio
3.33
2.56
332.47%
CMPX
Compass Therapeutics
5.53
3.88
235.15%
BCAX
Bicara Therapeutics Inc.
18.20
-2.94
-13.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis